<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01843101</url>
  </required_header>
  <id_info>
    <org_study_id>OPHT-040413</org_study_id>
    <nct_id>NCT01843101</nct_id>
  </id_info>
  <brief_title>Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study</brief_title>
  <official_title>Investigation of Different Scanning Protocols for 3 Dimensional High-resolution Imaging of the Human Cornea With Optical Coherence Tomography (OCT) - A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the present study is to develop a protocol for optimal corneal 3-dimensional&#xD;
      imaging based on measurements in healthy volunteers. For this purpose, a customized&#xD;
      ultra-high resolution Spectral Domain OCT will be used. To validate whether the protocol can&#xD;
      also be applied in patients with corneal pathologies, for whom it is intended to be used,&#xD;
      measurements in these patients will be performed. We propose to obtain images from patients&#xD;
      with keratoconus, since this is one of the most frequent causes for corneal transplantations&#xD;
      in Europe and from patients with corneal neovascularization which is a major cause of vision&#xD;
      loss in several ophthalmic diseases. Based on the obtained measurement protocol, further&#xD;
      studies investigating the pathophysiology or treatment success of several corneal pathologies&#xD;
      can be planned.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 14, 2014</start_date>
  <completion_date type="Actual">October 24, 2016</completion_date>
  <primary_completion_date type="Actual">October 24, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Corneal Imaging</measure>
    <time_frame>1 day</time_frame>
    <description>Development of a measurement protocol for 3 dimensional imaging of the human cornea</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Imaging of corneal pathologies</measure>
    <time_frame>1 day</time_frame>
    <description>Application of the protocol in patients with corneal pathologies</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">13</enrollment>
  <condition>Corneal Neovascularisation</condition>
  <condition>Keratoconus</condition>
  <arm_group>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>10 healthy volunteers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Corneal Neovascularisation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5 patients with corneal neovascularisation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Keratoconus</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>5 patients with keratoconus</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Optical Coherence Tomography</intervention_name>
    <description>Imaging of the cornea using ultrahigh resolution Spectral Domain OCT</description>
    <arm_group_label>Corneal Neovascularisation</arm_group_label>
    <arm_group_label>Healthy volunteers</arm_group_label>
    <arm_group_label>Keratoconus</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Healthy volunteers:&#xD;
&#xD;
          -  Men and women aged over 18 years&#xD;
&#xD;
          -  Normal findings in the slit lamp examination, no corneal pathologies&#xD;
&#xD;
        Patients with keratoconus:&#xD;
&#xD;
          -  Men and women aged over 18 years&#xD;
&#xD;
          -  Presence of keratoconus&#xD;
&#xD;
          -  No ophthalmic surgery in the 3 months preceding the study&#xD;
&#xD;
        Patients with corneal neovascularization:&#xD;
&#xD;
          -  Men and women aged over 18 years&#xD;
&#xD;
          -  Presence of corneal neovascularization&#xD;
&#xD;
          -  No ophthalmic surgery in the 3 months preceding the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Participation in a clinical trial in the previous 3 weeks&#xD;
&#xD;
          -  Presence of any abnormalities preventing reliable measurements as judged by the&#xD;
             investigator&#xD;
&#xD;
          -  Pregnancy, planned pregnancy or lactating&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katarzyna Napora, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Clinical Pharmacology, Medical University of Vienna</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Clinical Pharmacology</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 26, 2013</study_first_submitted>
  <study_first_submitted_qc>April 29, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 30, 2013</study_first_posted>
  <last_update_submitted>August 31, 2021</last_update_submitted>
  <last_update_submitted_qc>August 31, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 8, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Gerhard Garhofer</investigator_full_name>
    <investigator_title>Assoc. Prof. PD Dr.</investigator_title>
  </responsible_party>
  <keyword>Optical Coherence Tomography</keyword>
  <keyword>Cornea</keyword>
  <keyword>Imaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Keratoconus</mesh_term>
    <mesh_term>Corneal Neovascularization</mesh_term>
    <mesh_term>Neovascularization, Pathologic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

